位置：成果数据库 > 期刊 > 期刊详情页
Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everol
  • ISSN号：0167-6997
  • 期刊名称：Investigational New Drugs
  • 时间：2012.2.2
  • 页码：223-235
  • 相关项目：BAFF/NF-κB/Bcl-xL通路诱导弥漫大B细胞性淋巴瘤对抗CD20单抗联合化疗的方案耐药的机制及干预研究
作者： Huang, Jia-Jia|Li, Zhi-Ming|Huang, Ying|Huang, Yan|Tian, Ying|He, Xue-Xin|Xiao, Jian|Lin, Tong-Yu|
同期刊论文项目
BAFF/NF-κB/Bcl-xL通路诱导弥漫大B细胞性淋巴瘤对抗CD20单抗联合化疗的方案耐药的机制及干预研究
期刊论文 7
同项目期刊论文
High Ki-67 expression in diffuse large B-cell lymphoma patients with non-germinal center subtype ind
Expression of BAFF and BAFF-R in Follicular Lymphoma: Correlation with Clinicopathologic Characteris
Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Tr
CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: A matched case-control
Beclin 1 expression predicts favorable clinical outcome in patients with diffuse large B-cell lympho
血清白蛋白在经典型霍奇金淋巴瘤的临床意义